Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-549 |
filingDate |
2002-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07ea1a7253c2c2b2580cd72d5948384a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_020aaa95fa2e077311482849bdb27c3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a304c22f234a688bbf1ab49febe362a |
publicationDate |
2003-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
DE-10215240-A1 |
titleOfInvention |
Use of Ca2 + sensitisers for the treatment of chronic atrial fibrillation |
abstract |
The invention relates to the use of compounds selected from the group of Ca 2+ sensitizers and their pharmaceutically usable derivatives, solvates and stereoisomers, including their mixtures in all ratios, for the manufacture of a medicament for the treatment of chronic atrial fibrillation (atrial fibrillation). , |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112500353-A |
priorityDate |
2002-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |